MIRM
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. (MIRM) has 11 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.
Insiders have net sold $7.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Christopher Peetz
- Employees:334
- HQ:Foster City, CA, US
- IPO:2019-07-18
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.6M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Market Cap
$7.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CHIEF EXECUTIVE OFFICER | Sale | 20,000 | $2.4M | Jul 8 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 5,000 | $611K | Jul 8 | SEC ↗ | |
| SVP, GLOBAL CONTROLLER | Sale | 2,721 | $327K | Jul 2 | SEC ↗ | |
Howe JolandaFirst filing | SVP, GLOBAL CONTROLLER | Sale | 2,594 | $264K | Jun 18 | SEC ↗ |
BJERKHOLT ERICFirst filing | CHIEF FINANCIAL OFFICER | Sale | 5,000 | $469K | Jun 10 | SEC ↗ |
Peetz ChristopherFirst filing | CHIEF EXECUTIVE OFFICER | Sale | 30,000 | $2.9M | Jun 2 | SEC ↗ |
| Director | Sale | 3,977 | $398K | Jun 2 | SEC ↗ | |
Ramasastry SairaFirst filing | Director | Sale | 2,000 | $219K | May 19 | SEC ↗ |
Related companies
Mirum Pharmaceuticals, Inc. is in the Healthcare sector.